Sacha , T. “Deep Molecular Response (MR4.5) As a Target of Therapy With Tyrosine Kinase Inhibitors. MR4.5 – Goal of CML Treatment”. OncoReview, Vol. 4, no. 1(13), Mar. 2014, pp. 26-32, https://journalsmededu.pl/index.php/OncoReview/article/view/356.